Your browser doesn't support javascript.
loading
Functional Outcome and Safety of Intracranial Thrombectomy After Emergent Extracranial Stenting in Acute Ischemic Stroke Due to Tandem Occlusions.
Bücke, Philipp; Aguilar Pérez, Marta; AlMatter, Muhammad; Hellstern, Victoria; Bäzner, Hansjörg; Henkes, Hans.
Afiliação
  • Bücke P; Neurologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
  • Aguilar Pérez M; Klinik für Neuroradiologie, Klinikum Stuttgart, Stuttgart, Germany.
  • AlMatter M; Klinik für Neuroradiologie, Klinikum Stuttgart, Stuttgart, Germany.
  • Hellstern V; Klinik für Neuroradiologie, Klinikum Stuttgart, Stuttgart, Germany.
  • Bäzner H; Neurologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
  • Henkes H; Klinik für Neuroradiologie, Klinikum Stuttgart, Stuttgart, Germany.
Front Neurol ; 9: 940, 2018.
Article em En | MEDLINE | ID: mdl-30524353
ABSTRACT
Background and

Purpose:

Various endovascular approaches to treat acute ischemic stroke caused by extra- intracranial tandem occlusions (TO) exist percutaneous transluminal angioplasty with or without emergent extracranial carotid stenting (ECS) due to high-grade stenosis preceded or followed by intracranial mechanical and/or aspiration thrombectomy (MT). Which treatment strategy to use is still a matter of debate.

Methods:

From our ongoing prospective stroke registry we retrospectively analyzed 1,071 patients with anterior circulation stroke getting endovascular treatment within 6 h of symptom onset. ECS prior to intracranial MT for TO (n = 222) was compared to MT as standard of care (control group; acute intracranial vessel occlusion without concomitant ipsilateral ICA-occlusion or high-grade stenosis [C; n = 849]). Good functional outcome (mRS ≤ 2 at 3 months), mortality rates, frequencies of symptomatic intracranial hemorrhage (sICH) and successful recanalization (Thrombolysis in Cerebral Infarction Score [TICI] 2b or 3) were assessed. In subgroup analyses we tried to detect possible influences of stroke etiology, dual inhibition of platelet aggregation (IPA; clopidogrel [CLO] n = 83; ticagrelor [TIC] n = 137; in combination with Aspirin) and intravenous thrombolysis (IVT).

Results:

Functional outcome was superior in TO (mRS 0-2 44.6%) when compared with controls (36.0%; OR [95% CI] 3.49 [1.59-7.67]; p = 0.002). There was no difference in all-cause mortality at 3 months (TO 21.6%; C 27.7%; 0.78 [0.47-1.29]; p = 0.324), in-hospital mortality (0.76 [0.45-1.30]; p = 0.324), sICH (TO 3.2%; C 5.0%; 0.70 [0.30-1.59]; p = 0.389), and TICI 2b/3 (TO 89.1%; C 88.3%; p = 0.813). In subgroup-analysis, TIC and CLO did not differ in functional outcome (TIC 45.3%; CLO 44.6%; 1.04 [0.51-2.09]; p = 0.920) and mortality rates (all-cause mortality TIC 23.4%; CLO 16.9%; 0.75 [0.27-2.13]; p = 0.594). sICH was more frequent in TIC (n = 7 [5.1%]) vs. CLO (n = 0; p = 0.048).

Conclusion:

In our pre-selected cohort, ECS prior to intracranial MT in TO allowed for a good functional outcome that was superior compared to a control population. Mortality rates did not differ. Despite a dual IPA in TO, there was no increase in sICH. CLO and TIC for dual IPA did not differ in terms out outcome and mortality rates. A significant increase in sICH was observed after initial loading with TIC.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article